Results 241 to 250 of about 2,811,792 (409)

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition

Circulation, 2016
Scott A. Hubers, N. Brown
semanticscholar   +1 more source

Projecting the benefit of vericiguat in PARADIGM‐HF and DAPA‐HF populations: Insights from the VICTORIA trial

ESC Heart Failure, Volume 12, Issue 2, Page 1479-1484, April 2025.
Abstract Aims The VICTORIA trial demonstrated a significant reduction in the primary composite outcome of heart failure (HF) hospitalization or cardiovascular death with vericiguat relative to placebo in high‐risk HF. This study aimed to contextualize treatment effects of vericiguat in populations with varying risk profiles simulated from the PARADIGM ...
Veraprapas Kittipibul, Robert J. Mentz, Rebecca Young, Javed Butler, Justin A. Ezekowitz, Carolyn S.P. Lam, Piotr Ponikowski, Adriaan Voors, Stefano Corda, Ciaran McMullan, Christopher M. O'Connor, Kevin J. Anstrom, Paul W. Armstrong, for the VICTORIA Study Group   +13 more
wiley   +1 more source

Aldosterone downregulates delayed rectifier potassium currents through an angiotensin type 1 receptor-dependent mechanism.

, 2018
Yankun Lv, Yanjun Wang, Xiaoran Zhu, Hua Zhang   +3 more
openalex   +1 more source

Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022

ESC Heart Failure, Volume 12, Issue 2, Page 1283-1294, April 2025.
Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié, Richard Isnard, Françoise Pousset, Clémence Grave, Jacques Blacher, Amélie Gabet   +5 more
wiley   +1 more source

Long-term effectiveness of ACE inhibitors or angiotensin receptor blockers in myocardial infarction with preserved left ventricular ejection fraction. [PDF]

Eur Heart J Cardiovasc Pharmacother
Humphreys ABC, Lindahl B, Berglund A, Voelskow V, Fang S, Fröbert O, Hofmann R, Jernberg T, Hernán MA, Matthews AA.   +9 more
europepmc   +1 more source

Localization of angiotensin II receptors in ovarian follicles and the identification of angiotensin II in rat ovaries.

, 1987
Ahsan Husain, F. Merlin Bumpus, P De Silva, Robert C. Speth   +3 more
openalex   +2 more sources

Complement 5a Receptor Mediates Angiotensin II–Induced Cardiac Inflammation and Remodeling [PDF]

, 2014
Congcong Zhang, Yulin Li, Chunxiao Wang, Yina Wu, Wei Cui, Takashi Miwa, Sayaka Sato, Huihua Li, Wen‐Chao Song, Jie Du   +9 more
openalex   +1 more source

LCZ696, an angiotensin receptor–neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin‐induced diabetic mice

European Journal of Heart Failure, 2016
Yasunori Suematsu, S. Miura, Masaki Goto, Yoshino Matsuo, Tadaaki Arimura, T. Kuwano, S. Imaizumi, A. Iwata, E. Yahiro, K. Saku   +9 more
semanticscholar   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure. [PDF]

ESC Heart Fail
Jung MH, Cho DH, Choi J, Kim MN, Lee CJ, Son JW, Kim Y, Youn JC, Yoo BS.   +8 more
europepmc   +1 more source